Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria - Castro, Carlos de; Hillmen, Peter; Szer, Jeff; Weitz, Ilene; Röth, Alexander; Hoechsmann, Britta; Panse, Jens; Usuki, Kensuke; Griffin, Morag; Kiladjian, Jean-Jacques; Nishimori, Hisakazu; Tan, Lisa; et al. (Blood, 2020)